Next Capital Raise (when?), page-64

General market wariness when it comes to Azure.

Yes, you haven't exactly been helping there have you Mossberg? There is a general lack of understanding about Mexico, the cost structure, the safety reality (it's safe where we operate), etc. But your comment overlooks that and seems to imply the wariness is justified.

underwhelming Oposura assays

What were you expecting? We've got a target based on previous results under Canadian system...so where is this not being met? The problem with your statement is if that or similar ones are made repeatedly they almost develop a halo of truth.

Analysts tend to go: oh that old thing...it's human nature.

(If we get listed on the TSX this will all change pronto).